title: [Status of clinical trials in oncology--2013 and onwards].
abstract: Clinical trials connect basic science with patient care. They form the backbone of evidence-based medicine and clinical guidelines. The unprecedented implementation of new methods in oncology over the past 40 years has only been possible on the basis of multiple well-organized clinical study groups. The continued existence of these study groups in their current multitude is in danger. Far-reaching changes in the legal framework, underfunding, new definitions of patient-related outcome and shifts in the organization of cancer patient care ask for critical reappraisal and new concepts.
authors.affiliation: Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie, Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie, Campus Virchow Klinikum, Berlin, Deutschland. Woermann@dgho.de
authors.forename: Bernhard
authors.initials: B
authors.lastname: Wörmann
authors.forename: Mathias
authors.initials: M
authors.lastname: Freund
authors.forename: Friedrich
authors.initials: F
authors.lastname: Overkamp
authors.forename: Gerhard
authors.initials: G
authors.lastname: Ehninger
mesh_terms: D035843:Biomedical Research / Q000639:trends*; D002986:Clinical Trials as Topic / Q000639:trends*; D019317:Evidence-Based Medicine / Q000639:trends*; D005858:Germany; D008495:Medical Oncology / Q000639:trends*; D018802:Patient-Centered Care / Q000639:trends*